Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience

The novel 2019 coronavirus (COVID-19) was first described in December 2019 in Wuhan, China and subsequently announced as a pandemic on March 12, 2020. In several studies, solid-organ transplant recipients were reported to have higher risk for COVID-19. Here, we aimed to determine the frequency of CO...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental and clinical transplantation 2020-06, Vol.18 (3), p.270-274
Hauptverfasser:	Akdur, Aydincan, Karakaya, Emre, Ayvazoglu Soy, Ebru H, Alshalabi, Omar, Kirnap, Mahir, Arslan, Hande, Ulubay, Gaye, Hekimoglu, Koray, Moray, Gokhan, Haberal, Mehmet
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus - immunology Betacoronavirus - pathogenicity Coronavirus Infections - diagnosis Coronavirus Infections - epidemiology Coronavirus Infections - immunology Coronavirus Infections - virology COVID-19 Drug Therapy, Combination Female Host-Pathogen Interactions Humans Immunocompromised Host Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Kidney Transplantation - adverse effects Liver Transplantation - adverse effects Male Opportunistic Infections - diagnosis Opportunistic Infections - epidemiology Opportunistic Infections - immunology Opportunistic Infections - virology Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - epidemiology Pneumonia, Viral - immunology Pneumonia, Viral - virology Retrospective Studies Risk Assessment Risk Factors SARS-CoV-2 Tıp Treatment Outcome Turkey - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!